Assembly Biosciences Inc - Asset Resilience Ratio

Latest as of March 2026: 83.00%

Assembly Biosciences Inc (ASMB) has an Asset Resilience Ratio of 83.00% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Assembly Biosciences Inc strategic asset allocation index to assess the company's strategic physical and investment asset allocation.

Liquid Assets

$195.48 Million

Cash + Short-term Investments

Total Assets

$235.51 Million

All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2011–2025)

This chart shows how Assembly Biosciences Inc's Asset Resilience Ratio has changed over time. See how leveraged is Assembly Biosciences Inc's balance sheet to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Assembly Biosciences Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Assembly Biosciences Inc market cap and net worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$195.48 Million	83.0%
Total Liquid Assets	$195.48 Million	83.00%

Asset Resilience Insights

Very High Liquidity: Assembly Biosciences Inc maintains exceptional liquid asset reserves at 83.00% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Assembly Biosciences Inc Industry Peers by Asset Resilience Ratio

Compare Assembly Biosciences Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Cyclacel Pharmaceuticals Inc NASDAQ:CYCC	Biotechnology	-55.36%
Krystal Biotech Inc NASDAQ:KRYS	Biotechnology	23.06%
Verona Pharma PLC ADR NASDAQ:VRNA	Biotechnology	0.00%
Centessa Pharmaceuticals PLC ADR NASDAQ:CNTA	Biotechnology	33.37%
Beijing Tiantan Biological Products Corp Ltd SHG:600161	Biotechnology	8.08%
Hebei Changshan Biochem Pharma SHE:300255	Biotechnology	-0.03%
BB Biotech AG SW:BION	Biotechnology	0.05%

Annual Asset Resilience Ratio for Assembly Biosciences Inc (2011–2025)

The table below shows the annual Asset Resilience Ratio data for Assembly Biosciences Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	73.63%	$189.66 Million	$257.59 Million	+11.75pp
2024-12-31	61.87%	$73.73 Million	$119.17 Million	-18.82pp
2023-12-31	80.69%	$110.41 Million	$136.82 Million	+42.19pp
2022-12-31	38.50%	$39.19 Million	$101.79 Million	-14.36pp
2021-12-31	52.86%	$101.00 Million	$191.06 Million	-2.55pp
2020-12-31	55.42%	$156.97 Million	$283.25 Million	-9.92pp
2019-12-31	65.34%	$227.31 Million	$347.89 Million	-0.55pp
2018-12-31	65.89%	$176.61 Million	$268.05 Million	+43.49pp
2017-12-31	22.39%	$37.91 Million	$169.30 Million	-2.46pp
2016-12-31	24.86%	$24.39 Million	$98.12 Million	-5.47pp
2015-12-31	30.32%	$40.56 Million	$133.74 Million	--
2014-12-31	0.00%	$0.00	$71.23 Million	--
2013-12-31	0.00%	$0.00	$27.13 Million	--
2012-12-31	0.00%	$0.00	$20.56 Million	--
2011-12-31	0.00%	$0.00	$37.05 Million	--

pp = percentage points

About Assembly Biosciences Inc

NASDAQ:ASMB USA Biotechnology

Market Cap

$478.59 Million

Market Cap Rank

#13025 Global

#3131 in USA

Share Price

$24.15

Change (1 day)

+3.51%

52-Week Range

$17.08 - $38.50

All Time High

$769.92